Weekly Insider Buys: Biotech & Medical Stocks
by Hisham S. Ayoub, DMD
BioHealth Investor
Following data represents stock purchases by company insiders during the past week. This report may not be accurate or complete, and readers should not base their investment decisions on the following information.
July 9 - July 13
Advanced Medical Optics (EYE): $34.64 - $34.77 by Beneficial Owner
Biomerica (BMRA): $0.70-$0.75 by Director
Bioenvision (BIVN): $5.60 by Beneficial Owner
Chelsea Therapeutics (CHTP): $6.98 by Beneficial Owner
Cyberonics (CYBX): $16.83-$17.32 by Director
Enzon Pharmaceuticals (ENZN): $7.71-$7.73 by Beneficial Owner
Genaera (GENR): $2.63-$2.81 by Beneficial Owner
Health Systems Solutions (HSSO): $2.00 by Beneficial Owner
Human Genome Sciences (HGSI): $7.59-$8.99 by Officers & Directors
MGT Capital Investments (MGT): $5.00 by Chairman/CEO
Novogen (NVGN): $8.40 by Beneficial Owner
ReGen Biologics (RGBI): $0.38 by Vice President
Zila (ZILA): $1.26-$1.28 by Executive Vice President and Director
BioHealth Investor.com
___________________
BioHealth Investor
Following data represents stock purchases by company insiders during the past week. This report may not be accurate or complete, and readers should not base their investment decisions on the following information.
July 9 - July 13
Advanced Medical Optics (EYE): $34.64 - $34.77 by Beneficial Owner
Biomerica (BMRA): $0.70-$0.75 by Director
Bioenvision (BIVN): $5.60 by Beneficial Owner
Chelsea Therapeutics (CHTP): $6.98 by Beneficial Owner
Cyberonics (CYBX): $16.83-$17.32 by Director
Enzon Pharmaceuticals (ENZN): $7.71-$7.73 by Beneficial Owner
Genaera (GENR): $2.63-$2.81 by Beneficial Owner
Health Systems Solutions (HSSO): $2.00 by Beneficial Owner
Human Genome Sciences (HGSI): $7.59-$8.99 by Officers & Directors
MGT Capital Investments (MGT): $5.00 by Chairman/CEO
Novogen (NVGN): $8.40 by Beneficial Owner
ReGen Biologics (RGBI): $0.38 by Vice President
Zila (ZILA): $1.26-$1.28 by Executive Vice President and Director
BioHealth Investor.com
___________________
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home